These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7356532)
1. Correspondence re: H. J. Rapp and H. B. Hewitt. Appropriateness of animal models for the immunology of human cancer. Black MM; Zachrau RE Cancer Res; 1980 Feb; 40(2):492. PubMed ID: 7356532 [No Abstract] [Full Text] [Related]
2. Appropriateness of animal models for the immunology of human cancer. Rapp HJ Cancer Res; 1979 Oct; 39(10):4285-7. PubMed ID: 476659 [No Abstract] [Full Text] [Related]
3. Second counterpoint: animal tumor models and their relevance to human tumor immunology. Herberman RB J Biol Response Mod; 1983; 2(3):217-26. PubMed ID: 6644338 [No Abstract] [Full Text] [Related]
4. Immunology of tumours. Surján M Ther Hung; 1970; 18(2):55-62. PubMed ID: 4920764 [No Abstract] [Full Text] [Related]
6. The human model: a genetic dissection of immunity to infection in natural conditions. Casanova JL; Abel L Nat Rev Immunol; 2004 Jan; 4(1):55-66. PubMed ID: 14704768 [TBL] [Abstract][Full Text] [Related]
10. [Animal models in oro-dental research]. Jasmin C; Jasmin JR; Brocheriou C Actual Odontostomatol (Paris); 1984 Dec; 38(148):723-43. PubMed ID: 6399810 [No Abstract] [Full Text] [Related]
11. Counterpoint: animal tumor models and their relevance to human tumor immunology. Herberman RB J Biol Response Mod; 1983; 2(1):39-46. PubMed ID: 6644330 [No Abstract] [Full Text] [Related]
12. The study of human neoplastic disease in severe combined immunodeficient mice. Williams SS; Alosco TR; Croy BA; Bankert RB Lab Anim Sci; 1993 Apr; 43(2):139-46. PubMed ID: 8320961 [TBL] [Abstract][Full Text] [Related]
13. Animal models of tumor immunity, immunotherapy and cancer vaccines. Ostrand-Rosenberg S Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405 [TBL] [Abstract][Full Text] [Related]
14. Experimental mouse tumour models: what can be learnt about human cancer immunology? Dranoff G Nat Rev Immunol; 2011 Dec; 12(1):61-6. PubMed ID: 22134155 [TBL] [Abstract][Full Text] [Related]
15. [Tumor genesis as an immunologic problem]. Rapp W Med Welt; 1972 May; 23(21):788-92. PubMed ID: 5040396 [No Abstract] [Full Text] [Related]
17. Report of group B of the American Cancer Society Research Workshop on Cancer and Nutrition: panel on animal studies. Cancer Res; 1993 May; 53(10 Suppl):2452s-2454s. PubMed ID: 8485737 [No Abstract] [Full Text] [Related]
18. Promises and limitations of murine models in the development of anticancer T-cell vaccines. Lévy F; Colombetti S Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777 [TBL] [Abstract][Full Text] [Related]
19. Hyperthermia and immunity. A brief overview. Baronzio G; Gramaglia A; Fiorentini G In Vivo; 2006; 20(6A):689-95. PubMed ID: 17203747 [TBL] [Abstract][Full Text] [Related]
20. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth. Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]